Anoro Ellipta vs. Incruse Ellipta

• Are Anoro Ellipta and Incruse Ellipta he Same Thing?
• What Are Possible Side Effects of Anoro Ellipta?
• What Are Possible Side Effects of Incruse Ellipta?
• What is Anoro Ellipta?
• What is Incruse Ellipta?
• What Drugs Interact with Anoro Ellipta?
• What Drugs Interact with Incruse Ellipta?
• How Should Anoro Ellipta Be Taken?
• How Should Incruse Ellipta Be Taken?

Anoro Ellipta (umeclidinium and vilanterol) Inhalation Powder and Incruse Ellipta (umeclidinium) Inhalation Powder are used for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.

Anoro Ellipta and Incruse Ellipta both contain an anticholinergic. Anoro Ellipta also contains a long acting beta-adrenoceptor agonist (LABA).

Side effects of Anoro Ellipta and Incruse Ellipta that are similar include sore throat, sinusitis, respiratory tract infection, constipation, muscle spasms/pain, chest pain or discomfort, cough, stomach/abdominal pain, and fast or irregular heartbeats.

Side effects of Anoro Ellipta that are different from Incruse Ellipta include diarrhea, pain in extremities, neck pain, indigestion, gastroesophageal reflux disease (GERD), vomiting, weakness, itching, rash, conjunctivitis, hypersensitivity reactions including anaphylaxis and hives, changes in taste, tremor, and anxiety.

Side effects of Incruse Ellipta that are different from Anoro Ellipta include stuffy or runny nose, joint pain, tooth pain, and bruising or dark areas of skin.

Both Anoro Ellipta and Incruse Ellipta may interact with other anticholinergic drugs.

Anoro Ellipta may also interact with monoamine oxidase inhibitors (MAOIs), antidepressants, beta-blockers, and diuretics (water pills).

Common side effects of Anoro Ellipta include:

• sore throat,
• sinusitis,
• respiratory tract infection,
• constipation,
• diarrhea,
• pain in extremities,
• muscle spasms,
• neck pain,
• chest pain or discomfort,
• cough,
• indigestion,
• abdominal pain,
• gastroesophageal reflux disease (GERD),
• vomiting,
• weakness,
• irregular heart beats,
• itching,
• rash,
• conjunctivitis,
• palpitations,
• hypersensitivity reactions including anaphylaxis and hives,
• changes in taste,
• tremor, and
• anxiety.

Common side effects of Incruse Ellipta include:

• upper respiratory infection,
• stuffy or runny nose,
• cough,
• sore throat,
• joint pain,
• muscle pain,
• tooth pain,
• stomach pain,
• bruising or dark areas of skin,
• chest pain,
• fast or irregular heartbeat, and
• constipation.

Anoro Ellipta (umeclidinium and vilanterol) Inhalation Powder is a combination anticholinergic and long acting beta-adrenoceptor agonist (LABA) used for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.

Incruse Ellipta (umeclidinium) Inhalation Powder is an anticholinergic drug used for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.

Anoro Ellipta may interact with monoamine oxidase inhibitors (MAOIs), antidepressants, beta blockers, diuretics, and other anticholinergic drugs. Tell your doctor all medications and supplements you use. During pregnancy, Anoro Ellipta should be used only if prescribed. Tell your doctor if you are pregnant before taking Anoro Ellipta or if you become pregnant during treatment. It is unknown if this drug passes into breast milk. Consult your doctor before breastfeeding.

Incruse Ellipta may interact with other anticholinergic drugs. Tell your doctor all medications and supplements you use. During pregnancy, Incruse Ellipta should be taken only if prescribed. It is unknown if this drug passes into breast milk. Consult your doctor before breastfeeding.

Anoro Ellipta is administered as 1 inhalation dose once daily by the orally inhaled route only.

Incruse Ellipta (umeclidinium 62.5 mcg) should be administered as 1 inhalation dose once daily by the orally inhaled route only. Incruse Ellipta may interact with other anticholinergic drugs. Tell your doctor all medications and supplements you use.